Application of cryopreserved cells to HERG screening using a non-radioactive Rb+ efflux assay

Assay and Drug Development Technologies
Mei DingNan Albertson

Abstract

The aim of the present study was to test the use of cryopreserved cells for human ether-ago- go (hERG) channel screening. A stable Chinese hamster ovary-K1 cell line expressing hERG channels was used in a non-radioactive Rb+ efflux assay for screening hERG channel activity. Cells prepared from normal cultures and following cryopreservation were compared with regard to time course of Rb+ efflux response at different concentrations of KCl, overall cell morphology, signal-to noise assay window, assay robustness, and 50% inhibitory concentration (IC50) of the hERG blocker dofetilide. Our results showed that cryopreserved hERG-expressing cells at 1, 2, and 3 days following plating at different cell densities had no obvious morphological changes in comparison to the growing cells. The assay window, Z' factor, and IC50 of dofetilide were also very similar in all series of cells tested. It was concluded that the cryopreserved hERG cells prepared using the protocol described are as effective as growing hERG cells in the non-radioactive Rb+ efflux assay.

References

Jun 6, 2000·Journal of Biomolecular Screening·J H ZhangK R Oldenburg
Mar 15, 2002·Drug Discovery Today·Paul A Johnston, Patricia A Johnston
May 29, 2002·Experimental Hematology·Robert S HauptscheinDaniel G Jay
Jan 27, 2005·Assay and Drug Development Technologies·Kewei WangJohn Dunlop
Mar 31, 2005·Assay and Drug Development Technologies·Natalie FursovZhong Zhong
Mar 31, 2005·Assay and Drug Development Technologies·Priya KunapuliBerta Strulovici

❮ Previous
Next ❯

Citations

Dec 18, 2015·Archives of Toxicology·Xichun LiZhengyu Cao
Apr 8, 2010·Journal of Biomolecular Screening·Elissa A SwearingenPaul D Kassner
May 10, 2008·Journal of Biomolecular Screening·M J WigglesworthA Wise

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

© 2021 Meta ULC. All rights reserved